Cargando…
Effect of Very Low-Dose Hydrocortisone on Shock Reversal in Patients With Septic Shock
In patients with septic shock, hydrocortisone 200–400 mg/d has been shown to reverse shock compared with placebo. Lower doses of hydrocortisone have not previously been studied, and there are no previous studies comparing two different doses of hydrocortisone. At our institution, some clinicians rou...
Autores principales: | Sbertoli, Robert, Hu, Zeyu, Henke, Jonathan, Wu, Eric, Santosh, Shrihari, Osmon, Stephen, Charbek, Edward, Jamkhana, Zafar, Santosh, Sadashiv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188423/ https://www.ncbi.nlm.nih.gov/pubmed/32426738 http://dx.doi.org/10.1097/CCE.0000000000000096 |
Ejemplares similares
-
Timing, method and discontinuation of hydrocortisone administration for septic shock patients
por: Ibarra-Estrada, Miguel A, et al.
Publicado: (2017) -
Tocilizumab Versus Baricitinib in Patients Hospitalized With COVID-19 Pneumonia and Hypoxemia: A Multicenter Retrospective Cohort Study
por: Roddy, John, et al.
Publicado: (2022) -
Hydrocortisone in septic shock: is it worth it?
por: Young, Paul J.
Publicado: (2023) -
Early Albumin Infusion Is Associated With Greater Survival to Discharge Among Patients With Sepsis/Septic Shock Who Develop Severe Acute Kidney Injury Among Patients With Sepsis/Septic Shock Who Develop Severe Acute Kidney Injury
por: Raghunathan, Karthik, et al.
Publicado: (2022) -
Prediction of Impending Septic Shock in Children With Sepsis
por: Liu, Ran, et al.
Publicado: (2021)